These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. Elkayam U, Weber L, McKay CR, Rahimtoola SH. Am J Cardiol; 1984 Jul 01; 54(1):126-31. PubMed ID: 6741802 [Abstract] [Full Text] [Related]
4. Results of long-term vasodilator therapy in patients with refractory congestive heart failure. Walsh WF, Greenberg BH. Circulation; 1981 Sep 01; 64(3):499-505. PubMed ID: 7261282 [Abstract] [Full Text] [Related]
9. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure. Quyyumi AA, Wagstaff D, Evans TR. Am J Cardiol; 1983 May 01; 51(8):1353-7. PubMed ID: 6846162 [Abstract] [Full Text] [Related]
11. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW. Am J Cardiol; 1977 Nov 01; 40(5):794-801. PubMed ID: 411364 [Abstract] [Full Text] [Related]
12. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect. Beekman RH, Rocchini AP, Rosenthal A. Circulation; 1982 Mar 01; 65(3):523-8. PubMed ID: 6459891 [Abstract] [Full Text] [Related]
13. Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine. Packer M, Gorlin R, Meller J, Medina N. Clin Pharmacol Ther; 1982 Jul 01; 32(1):54-61. PubMed ID: 7083730 [Abstract] [Full Text] [Related]
14. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. Gogia H, Mehra A, Parikh S, Raman M, Ajit-Uppal J, Johnson JV, Elkayam U. J Am Coll Cardiol; 1995 Dec 01; 26(7):1575-80. PubMed ID: 7594088 [Abstract] [Full Text] [Related]
16. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure. Rubin LJ, Handel F, Peter RH. Circulation; 1982 Jun 01; 65(7):1369-73. PubMed ID: 7074795 [Abstract] [Full Text] [Related]
17. Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure. Artman M, Parrish MD, Appleton S, Boucek RJ, Graham TP. Am Heart J; 1987 Jan 01; 113(1):144-50. PubMed ID: 3799428 [Abstract] [Full Text] [Related]
19. Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance. Massie BM, Kramer B, Haughom F. Circulation; 1981 Dec 01; 64(6):1218-26. PubMed ID: 6794935 [Abstract] [Full Text] [Related]
20. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Nelson GI, Silke B, Forsyth DR, Verma SP, Hussain M, Taylor SH. Am J Cardiol; 1983 Nov 01; 52(8):1036-40. PubMed ID: 6637819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]